Skip to main content
. Author manuscript; available in PMC: 2020 Jul 1.
Published in final edited form as: Pediatrics. 2019 Jun 17;144(1):e20190414. doi: 10.1542/peds.2019-0414

TABLE 2.

Evidence-Based Recommendations for Measles Vaccination in International Travelers by Age Group (ACIP)

Age Group Recommendation Special Considerations
<6 mo Vaccine not recommended; consider avoiding unnecessary travel to countries with circulating measles N/A
6–11 mo Single dose of MMR vaccine If vaccinated before 12 mo of age, the child should be revaccinated with 2 doses
Dose 1: 12–15 mo of age
Dose 2: 28 d after dose 1
≥12 mo and adults Two doses of MMR (or MMRV) vaccine separated by at least 28 d Dose 1 should be administered at ≥12 mo of age

MMRV, measles-mumps-rubella-varicella; N/A, not applicable.